NCT03512795View on ClinicalTrials.gov

Optimization of HIV-1 DNA Genotyping by High Throughput Sequencing to Document Antiretroviral Resistant Mutations

CompletedOBSERVATIONAL
Enrollment

71

Participants

Timeline

Start Date

August 8, 2018

Primary Completion Date

March 5, 2020

Study Completion Date

March 5, 2020

Conditions
HIV-1-infection
Interventions
BIOLOGICAL

Blood samples

An additional blood tube will be taken during the patient's follow-up blood collection.

Trial Locations (1)

21000

Chu Dijon Bourogne, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT03512795 - Optimization of HIV-1 DNA Genotyping by High Throughput Sequencing to Document Antiretroviral Resistant Mutations | Biotech Hunter | Biotech Hunter